KORU Medical Systems Operating Margin 2010-2025 | KRMD
Current and historical operating margin for KORU Medical Systems (KRMD) over the last 10 years. The current operating profit margin for KORU Medical Systems as of June 30, 2025 is -12.24%.
| KORU Medical Systems Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.04B | $-0.01B | -13.51% |
| 2025-03-31 | $0.04B | $-0.01B | -17.14% |
| 2024-12-31 | $0.03B | $-0.01B | -21.21% |
| 2024-09-30 | $0.03B | $-0.01B | -22.58% |
| 2024-06-30 | $0.03B | $-0.01B | -23.33% |
| 2024-03-31 | $0.03B | $-0.01B | -31.03% |
| 2023-12-31 | $0.03B | $-0.01B | -35.71% |
| 2023-09-30 | $0.03B | $-0.01B | -39.29% |
| 2023-06-30 | $0.03B | $-0.01B | -37.93% |
| 2023-03-31 | $0.03B | $-0.01B | -41.38% |
| 2022-12-31 | $0.03B | $-0.01B | -42.86% |
| 2022-09-30 | $0.03B | $-0.01B | -40.74% |
| 2022-06-30 | $0.03B | $-0.01B | -40.00% |
| 2022-03-31 | $0.02B | $-0.01B | -29.17% |
| 2021-12-31 | $0.02B | $-0.01B | -26.09% |
| 2021-09-30 | $0.02B | $-0.01B | -23.81% |
| 2021-06-30 | $0.02B | $0.00B | -19.05% |
| 2021-03-31 | $0.02B | $0.00B | -17.39% |
| 2020-12-31 | $0.02B | $0.00B | -4.17% |
| 2020-09-30 | $0.03B | 0 | 0.00% |
| 2020-06-30 | $0.03B | $0.00B | 3.70% |
| 2020-03-31 | $0.02B | $0.00B | 8.33% |
| 2019-12-31 | $0.02B | $0.00B | 4.35% |
| 2019-09-30 | $0.02B | $0.00B | 4.76% |
| 2019-06-30 | $0.02B | 0 | 0.00% |
| 2019-03-31 | $0.02B | $0.00B | 5.26% |
| 2018-12-31 | $0.02B | $0.00B | 11.11% |
| 2018-09-30 | $0.02B | $0.00B | 12.50% |
| 2018-06-30 | $0.02B | $0.00B | 13.33% |
| 2018-03-31 | $0.01B | $0.00B | 7.14% |
| 2017-12-31 | $0.01B | 0 | 0.00% |
| 2017-06-30 | $0.01B | 0 | 0.00% |
| 2017-03-31 | $0.01B | 0 | 0.00% |
| 2016-11-30 | $0.01B | 0 | 0.00% |
| 2016-09-30 | $0.01B | 0 | 0.00% |
| 2016-06-30 | $0.01B | 0 | 0.00% |
| 2016-05-31 | $0.01B | $0.00B | 11.11% |
| 2015-08-31 | $0.01B | $0.00B | 11.11% |
| 2015-05-31 | $0.01B | 0 | 0.00% |
| 2014-08-31 | $0.01B | 0 | 0.00% |
| 2014-05-31 | $0.01B | 0 | 0.00% |
| 2013-08-31 | $0.01B | 0 | 0.00% |
| 2013-05-31 | $0.01B | $0.00B | 16.67% |
| 2012-05-31 | $0.00B | 0 | 0.00% |
| 2011-12-31 | $0.01B | $0.00B | -20.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.197B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.976B | 58.72 |
| Doximity (DOCS) | United States | $12.734B | 56.66 |
| Tempus AI (TEM) | United States | $12.722B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.947B | 81.50 |
| IRhythm Technologies (IRTC) | United States | $5.455B | 0.00 |
| Hinge Health (HNGE) | United States | $4.531B | 0.00 |
| Heartflow (HTFL) | $2.821B | 0.00 | |
| Inspire Medical Systems (INSP) | United States | $2.730B | 40.13 |
| Privia Health (PRVA) | United States | $2.669B | 197.73 |
| Phreesia (PHR) | United States | $1.904B | 0.00 |
| Enovis (ENOV) | United States | $1.773B | 9.37 |
| 10x Genomics (TXG) | United States | $1.745B | 0.00 |
| Omnicell (OMCL) | United States | $1.526B | 29.41 |
| Schrodinger (SDGR) | United States | $1.457B | 0.00 |
| Azenta (AZTA) | United States | $1.384B | 60.40 |
| Clover Health Investments (CLOV) | United States | $1.379B | 0.00 |
| Claritev (CTEV) | United States | $1.184B | 0.00 |
| Evolent Health (EVH) | United States | $1.130B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.542B | 0.00 |
| Veradigm (MDRX) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.489B | 0.00 |
| Talkspace (TALK) | United States | $0.454B | 135.50 |
| Butterfly Network (BFLY) | United States | $0.395B | 0.00 |
| Carlsmed (CARL) | United States | $0.369B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 52.95 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| Outset Medical (OM) | United States | $0.248B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.225B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.210B | 0.00 |
| CapsoVision (CV) | United States | $0.185B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.157B | 7.13 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.085B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.040B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| PROFUSA (PFSA) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |